
Ankay Drugs Private Limited
About Ankay Drugs Private Limited
Data last updated:
Ankay Drugs Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 March 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85190DL1996PTC077264. Its GSTIN is 07AABCA0606N1ZW (Delhi).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Pradip Jain and Lav Jain.
Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 3/33 (Block F – 3 Plot No – 33) Krishna Nagar, Delhi, India – 110051.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.66 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹4.75 Lakh (net margin 0.3%) and EBITDA of ₹22.38 Lakh (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹1.25 Cr and satisfied charges of ₹1.65 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Ankay Drugs has one previous CIN (Corporate Identification Number): U99999DL1996PTC077264. The current CIN is U85190DL1996PTC077264, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85190DL1996PTC077264 | Current |
| U99999DL1996PTC077264 | Previous |
Contact details
Ankay Drugs Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF – 3/33 (Block F – 3 Plot No – 33) Krishna Nagar, Delhi, India – 110051
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ankay Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ankay Drugs is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Ankay Drugs Private Limited, buy the company report.
Financials of Ankay Drugs Private Limited
FY 2025 filings availableAnkay Drugs Private Limited reported revenue of ₹14.66 Cr (down 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 1% fall in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ankay Drugs Private Limited, buy the company report.
Board of directors of Ankay Drugs Private Limited
Ankay Drugs has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradip Jain | Director | 18 Mar 1996 | 30 Years 7 Months | Current |
| Lav Jain | Director | 12 Feb 2007 | 19 Years 8 Months | Current |
| Preeti Jain | Director | 01 Apr 2014 | 12 Years 7 Months | Current |
Auditor
Ankay Drugs Private Limited is audited by AJAY ARUN MEHTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY ARUN MEHTA & ASSOCIATES | FY 2023 | 009051N |
Shareholding
The shareholding of Ankay Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ankay Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Oct 2020 | 100390617 | Others | ₹1.25 Cr | Open | |
| 09 Jul 2020 | 100360038 | Others | ₹99.92 Lakh | Satisfied | |
| 28 Sep 2010 | 10244875 | Lakshmi Vilas Bank Limited | ₹65 Lakh | Satisfied |
To see the full charge records of Ankay Drugs Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Ankay Drugs Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Court case (Civ Suit) | Filed against the company by M/S Morepen Laboratories Limited | Disposed |
To see the full case history of Ankay Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ankay Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ankay Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCA0606N1ZW | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ankay Drugs Private Limited, buy the company report.
Recent activity
Ankay Drugs Private Limited has 3 board changes on record since 1996: 3 appointments. The latest: Preeti Jain was appointed as Director on 01 Apr 2014.
Frequently asked questions
Ankay Drugs is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 March 1996 (30+ years old) and is registered under CIN U85190DL1996PTC077264.
Ankay Drugs has 3 current directors:
- Pradip Jain - Director
- Lav Jain - Director
- Preeti Jain - Director
The latest financial statements of Ankay Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ankay Drugs is 07AABCA0606N1ZW, registered in Delhi.
The CIN (Corporate Identification Number) of Ankay Drugs is U85190DL1996PTC077264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ankay Drugs has 1 court case on record: 1 filed against it.
Ankay Drugs was incorporated on 18 March 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
Preeti Jain was appointed as Director on 01 Apr 2014. Lav Jain was appointed as Director on 12 Feb 2007. Pradip Jain was appointed as Director on 18 Mar 1996.
The registered office of Ankay Drugs is at F – 333 Block F – 3 Plot No – 33 Krishna Nagar, Delhi, India – 110051.
Ankay Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

